Select Biosciences Ltd

Resorufin - a lead for a new protein kinase CK2 inhibitor

Iben Skjøth Sandholt1, Birgitte Brinkmann Olsen1, Barbara Guerra1, Olaf-Georg Issinger1, Brigitte Boldyreff2, 1Institute for Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark, 2KinaseDetect ApS, Forskerparken 10, 5230 Odense, Denmark

Date Posted: Saturday, February 21, 2009

Print Email to a friend

Screening of a natural compound library led to the identification of resorufin, as a highly selective and potent inhibitor for protein kinase CK2. Out of 52 kinases tested only CK2 was inhibited. The IC50 values determined for the CK2 holoenzymes were 1.5 µM and for the free catalytic subunits ca. 4 µM. In different cancer cell lines treatment with resorufin led to cell death and endogenous CK2 was inhibited.

Click here to open PDF

Comments about this Poster

Click Here to Leave a Comment about this Poster